Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kromek Group is a publicly traded UK detection technology company focused on radiation detection and bio-detection solutions for advanced imaging and CBRN applications. Its core differentiator is its cadmium zinc telluride (CZT) platform, which it uses to design and manufacture detector components, integrated modules and finished detection devices. In healthcare, Kromek supplies OEM detector technology for medical imaging systems including SPECT and CT, supporting applications such as cancer and Alzheimer's disease detection, and it is also advancing molecular breast imaging technology. Outside healthcare, the company sells products for civil nuclear, homeland security, defence and biological-threat detection markets. Kromek operates manufacturing sites in the UK and US and commercializes products globally through direct sales, OEM relationships and distribution partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kromek Group.